An 8-week treatment duration may be sufficient for certain endpoints driven by immune dysregulation and chronic inflammation.

“so i think that you know what we know about is part of it it wouldn't shock me if there was there were things we don't know about yet that also are contributing yeah but but getting back to this this eight week right that's how we got started so i tend to think based on my personal experience and the little bit of data from these two clinical trials that that's probably long enough for at least some endpoints that are driven primarily by immune dysregulation and chronic inflammation”